ABIONYX Pharma SA

€1.55As of Sun 8 Nov 2026, 12:00 UTC
EPA:ABNXHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (14.42%)
Div yield —
ROE (92.29%)
Biotechnology
Beta (5Y) 0.91
PE TTM —
TSR TTM (62.08%)
Mkt cap €65.62M
ROIC (115.47%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€1.60
3.41%
(81.44%)
Hold 11|3|2|10|5
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.02
0.02
0.02
0.02
15.08%
19.99%
19.46%
6.44%
Revenue€M
4.387
4.523
4.513
4.506
10.24%
16.43%
14.42%
7.86%
Peers (US$73.69M)
Cap (US$)
PE
102.3M
—
82.04M
—
61.82M
—
75.03M
—
Capital
TTM
5Y
10Y
Leveragex
0.125
0.731
0.555
EBIT/Intx
0.590
0.125
0.124
Own earn%
(6.68)
164.09
137.10
Sh yield%
32.97
27.12
30.53
Owners
Insiders/Inst%
11.77
88.44
Short interest%
1.09
SBC / revenue%
5.85
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
3–10
$1 testx
—
Incr. ROIC%
6